Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1378888
PUBLISHER: IMARC | PRODUCT CODE: 1378888
Pneumococcal Vaccine Market Report by Vaccine Type, Product Type, Distribution Channel (Distribution Partner Companies, Non-Governmental Organizations, Government Authorities), End User, and Region 2023-2028
PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
The global pneumococcal vaccine market size reached US$ 8.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2022-2028.
Pneumococcal disease is caused by Streptococcus pneumoniae bacterium that can lead to severe infection of the lungs (pneumonia) and blood (bacteremia) or the lining of the brain and spinal cord (meningitis). The vaccines help protect both children and adults by stimulating the immune system and protecting against the bacterial strains responsible for severe infections. As these vaccines help prevent infection from spreading, reduce fatality rate and eliminate the need for hospitalization, they are widely being used across the globe.
According to the World Health Organization (WHO), children under 2-5 years of age are at a high risk of developing pneumococcal disease. This, in confluence with the escalating number of birth rates and the growing concerns among parents about the health of their children, represents one of the major factors bolstering the market growth. Additionally, the increasing geriatric population is contributing to the market growth. This can also be accredited to the contagiousness of the disease, which can cause severe complications in older adults. Furthermore, the rising number of smokers and individuals living with chronic health conditions is positively influencing the market growth. Moreover, the introduction of the Pneumococcal Conjugate Vaccine (PCV) in infant routine immunization by governing agencies of numerous countries is anticipated to propel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global pneumococcal vaccine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, product type, distribution channel and end user.
Breakup by Vaccine Type:
Pneumococcal Conjugate Vaccine
Pneumococcal Polysaccharide Vaccine
Breakup by Product Type:
Prevnar 13
Synflorix
Pneumovax 23
Breakup by Distribution Channel:
Distribution Partner Companies
Non-Governmental Organizations (NGO)
Government Authorities
Breakup by End User:
Pediatrics
Adults
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., GlaxoSmithKline Plc., Merck & Co. Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt Ltd and Walvax Biotechnology Co. Ltd.
Key Questions Answered in This Report
- 1. What was the size of the global pneumococcal vaccine market in 2022?
- 2. What is the expected growth rate of the global pneumococcal vaccine market during 2023-2028?
- 3. What has been the impact of COVID-19 on the global pneumococcal vaccine market?
- 4. What are the key factors driving the global pneumococcal vaccine market?
- 5. What is the breakup of the global pneumococcal vaccine market based on the vaccine type?
- 6. What is the breakup of the global pneumococcal vaccine market based on the product type?
- 7. What is the breakup of the global pneumococcal vaccine market based on the distribution channel?
- 8. What are the key regions in the global pneumococcal vaccine market?
- 9. Who are the key players/companies in the global pneumococcal vaccine market?
Product Code: SR112023A3133
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Pneumococcal Vaccine Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Vaccine Type
- 6.1 Pneumococcal Conjugate Vaccine
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Pneumococcal Polysaccharide Vaccine
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Product Type
- 7.1 Prevnar 13
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Synflorix
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Pneumovax 23
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Distribution Partner Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Non-Governmental Organizations (NGO)
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Government Authorities
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Pediatrics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Adults
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Astellas Pharma Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 GlaxoSmithKline Plc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Merck & Co. Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Panacea Biotec Ltd.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Pfizer Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Sanofi S.A.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Serum Institute of India Pvt Ltd.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Walvax Biotechnology Co. Ltd.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.1 Astellas Pharma Inc.
Product Code: SR112023A3133
List of Figures
- Figure 1: Global: Pneumococcal Vaccine Market: Major Drivers and Challenges
- Figure 2: Global: Pneumococcal Vaccine Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Pneumococcal Vaccine Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Pneumococcal Vaccine Market: Breakup by Vaccine Type (in %), 2022
- Figure 5: Global: Pneumococcal Vaccine Market: Breakup by Product Type (in %), 2022
- Figure 6: Global: Pneumococcal Vaccine Market: Breakup by Distribution Channel (in %), 2022
- Figure 7: Global: Pneumococcal Vaccine Market: Breakup by End User (in %), 2022
- Figure 8: Global: Pneumococcal Vaccine Market: Breakup by Region (in %), 2022
- Figure 9: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 10: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 11: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 12: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 13: Global: Pneumococcal Vaccine (Prevnar 13) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 14: Global: Pneumococcal Vaccine (Prevnar 13) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 15: Global: Pneumococcal Vaccine (Synflorix) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 16: Global: Pneumococcal Vaccine (Synflorix) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 17: Global: Pneumococcal Vaccine (Pneumovax 23) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 18: Global: Pneumococcal Vaccine (Pneumovax 23) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 19: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 20: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 21: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 22: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 23: Global: Pneumococcal Vaccine (Government Authorities) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 24: Global: Pneumococcal Vaccine (Government Authorities) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 25: Global: Pneumococcal Vaccine (Pediatrics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 26: Global: Pneumococcal Vaccine (Pediatrics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 27: Global: Pneumococcal Vaccine (Adults) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 28: Global: Pneumococcal Vaccine (Adults) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 29: North America: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 30: North America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 31: United States: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 32: United States: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 33: Canada: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 34: Canada: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 35: Asia-Pacific: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 36: Asia-Pacific: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 37: China: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 38: China: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 39: Japan: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 40: Japan: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 41: India: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 42: India: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 43: South Korea: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 44: South Korea: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 45: Australia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 46: Australia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 47: Indonesia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 48: Indonesia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 49: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 50: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 51: Europe: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 52: Europe: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 53: Germany: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 54: Germany: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 55: France: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 56: France: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 57: United Kingdom: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 58: United Kingdom: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 59: Italy: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 60: Italy: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 61: Spain: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 62: Spain: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 63: Russia: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 64: Russia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 65: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 66: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 67: Latin America: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 68: Latin America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 69: Brazil: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 70: Brazil: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 71: Mexico: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 72: Mexico: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 73: Others: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 74: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 75: Middle East and Africa: Pneumococcal Vaccine Market: Sales Value (in Million US$), 2017 & 2022
- Figure 76: Middle East and Africa: Pneumococcal Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 77: Middle East and Africa: Pneumococcal Vaccine Market: Breakup by Country (in %), 2022
- Figure 78: Global: Pneumococcal Vaccine Industry: SWOT Analysis
- Figure 79: Global: Pneumococcal Vaccine Industry: Value Chain Analysis
- Figure 80: Global: Pneumococcal Vaccine Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Pneumococcal Vaccine Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Pneumococcal Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
- Table 3: Global: Pneumococcal Vaccine Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
- Table 4: Global: Pneumococcal Vaccine Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
- Table 5: Global: Pneumococcal Vaccine Market Forecast: Breakup by End User (in Million US$), 2023-2028
- Table 6: Global: Pneumococcal Vaccine Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 7: Global: Pneumococcal Vaccine Market: Competitive Structure
- Table 8: Global: Pneumococcal Vaccine Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.